785 related articles for article (PubMed ID: 28556921)
1. Membrane-bound Dickkopf-1 in Foxp3
Chae WJ; Park JH; Henegariu O; Yilmaz S; Hao L; Bothwell ALM
Immunology; 2017 Oct; 152(2):265-275. PubMed ID: 28556921
[TBL] [Abstract][Full Text] [Related]
2. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
[TBL] [Abstract][Full Text] [Related]
3. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M
Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665
[TBL] [Abstract][Full Text] [Related]
4. Wiskott-Aldrich syndrome protein deficiency in innate immune cells leads to mucosal immune dysregulation and colitis in mice.
Nguyen DD; Wurbel MA; Goettel JA; Eston MA; Ahmed OS; Marin R; Boden EK; Villablanca EJ; Paidassi H; Ahuja V; Reinecker HC; Fiebiger E; Lacy-Hulbert A; Horwitz BH; Mora JR; Snapper SB
Gastroenterology; 2012 Sep; 143(3):719-729.e2. PubMed ID: 22710191
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells.
Dominitzki S; Fantini MC; Neufert C; Nikolaev A; Galle PR; Scheller J; Monteleone G; Rose-John S; Neurath MF; Becker C
J Immunol; 2007 Aug; 179(4):2041-5. PubMed ID: 17675459
[TBL] [Abstract][Full Text] [Related]
6. Increased CD4
Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
[TBL] [Abstract][Full Text] [Related]
7. Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cells.
de Zoeten EF; Hancock WW
Gastroenterology; 2008 Jun; 134(7):2171-4. PubMed ID: 18482583
[No Abstract] [Full Text] [Related]
8. Ablation of peroxiredoxin II attenuates experimental colitis by increasing FoxO1-induced Foxp3+ regulatory T cells.
Won HY; Jang EJ; Lee K; Oh S; Kim HK; Woo HA; Kang SW; Yu DY; Rhee SG; Hwang ES
J Immunol; 2013 Oct; 191(8):4029-37. PubMed ID: 24048895
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
10. Lamin A/C deficiency in CD4
Toribio-Fernández R; Herrero-Fernandez B; Zorita V; López JA; Vázquez J; Criado G; Pablos JL; Collas P; Sánchez-Madrid F; Andrés V; Gonzalez-Granado JM
J Pathol; 2019 Dec; 249(4):509-522. PubMed ID: 31372995
[TBL] [Abstract][Full Text] [Related]
11. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
12. OX40 is required for regulatory T cell-mediated control of colitis.
Griseri T; Asquith M; Thompson C; Powrie F
J Exp Med; 2010 Apr; 207(4):699-709. PubMed ID: 20368580
[TBL] [Abstract][Full Text] [Related]
13. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease.
Du X; Shi H; Li J; Dong Y; Liang J; Ye J; Kong S; Zhang S; Zhong T; Yuan Z; Xu T; Zhuang Y; Zheng B; Geng JG; Tao W
J Immunol; 2014 Feb; 192(4):1525-35. PubMed ID: 24453252
[TBL] [Abstract][Full Text] [Related]
14. The NF-κB transcription factor RelA is required for the tolerogenic function of Foxp3(+) regulatory T cells.
Messina N; Fulford T; O'Reilly L; Loh WX; Motyer JM; Ellis D; McLean C; Naeem H; Lin A; Gugasyan R; Slattery RM; Grumont RJ; Gerondakis S
J Autoimmun; 2016 Jun; 70():52-62. PubMed ID: 27068879
[TBL] [Abstract][Full Text] [Related]
15. Delta-like 1-mediated Notch signaling enhances the in vitro conversion of human memory CD4 T cells into FOXP3-expressing regulatory T cells.
Mota C; Nunes-Silva V; Pires AR; Matoso P; Victorino RM; Sousa AE; Caramalho I
J Immunol; 2014 Dec; 193(12):5854-62. PubMed ID: 25367118
[TBL] [Abstract][Full Text] [Related]
16. Induced and thymus-derived Foxp3⁺ regulatory T cells share a common niche.
Huang YJ; Haist V; Baumgärtner W; Föhse L; Prinz I; Suerbaum S; Floess S; Huehn J
Eur J Immunol; 2014 Feb; 44(2):460-8. PubMed ID: 24170313
[TBL] [Abstract][Full Text] [Related]
17. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid Receptor-Deficient Foxp3
Rocamora-Reverte L; Tuzlak S; von Raffay L; Tisch M; Fiegl H; Drach M; Reichardt HM; Villunger A; Tischner D; Wiegers GJ
Front Immunol; 2019; 10():472. PubMed ID: 30936873
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis.
Yang R; Qu C; Zhou Y; Konkel JE; Shi S; Liu Y; Chen C; Liu S; Liu D; Chen Y; Zandi E; Chen W; Zhou Y; Shi S
Immunity; 2015 Aug; 43(2):251-63. PubMed ID: 26275994
[TBL] [Abstract][Full Text] [Related]
20. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
